Paradigm Global Events are proud to present the Monoclonal Antibodies 2014 Congress Europe. Latest Innovations on Discovery, Production and Application

Paradigm Global Events are proud to present the Monoclonal Antibodies 2014 Congress

Monoclonal Antibodies are also known as targeted therapies because they work by targeting specific proteins on the surface of the cells. Mabs agents are currently have been successfully used in the treatment of cancers, tumors and other serious diseases and is big on the market.

The market size of Monoclonal antibody agents in 2009-2012 grew at a CAGR of 13% and is expected to rise by more than 12% in 2013-2017 reaching 1 billion in 2017. This is due to great market demand, new products being approved and also launching of Mabs generic drugs.

The global industry of Mabs is currently dominated by European and American companies, however, sales of Mabs in the rest of the world will remain higher than in the U.S despite a higher CAGR in the U.S.

By Attending this conference you will:

Gain insight on various therapeutic targets
Learn the latest and most recent advances in antibody technology
Find out what is the future in antibody technology
Understanding about new antibody engineering and modification technologies
Explore up to date platform approaches to monoclonal antibody purification
Learn new techniques in cell engineering for Mabs production
Examine antibody-based targeted therapy
Study the latest trends in capacity utilization for therapeutic mabs production
Investigate immunogenicity issues with drug development
Hear about latest regulations, technologies, production and therapeutics


Who should attend:

VP’s, Directors, Heads and Managers of:

Antibody Development
Preclinical research development
Clinical Research development
Cell and Molecular Biology
Recombitant DNA Biotechnology
Auto-immune Disorders
Pharmaceutical and Patent Law
Contract research Organizations
Clinical Diagnostics
New product development
Oncology R&D
Business Development
Marketing

More details

Find an actor

9th International Conference on Structural Biology18.09.2017

Structural Biology 2017 gladly welcomes all the participants from all over the world to join the upcoming prestigious...

Welcome To Health Valley

Building on skills honed over the centuries, western Switzerland has become a world leader in biotech.
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn